Eli Lilly and (LLY) Stock Forecast & Price Target
Score
Eli Lilly and Company price target
| LLY | |
|---|---|
| Low | $940.00 |
| Average | $1,442.61 |
| High | $1,650.00 |
| Upside vs current price | +0.3% |
The average target of $1,442.61 is +0.3% versus the current LLY price of $1,437.76.
Eli Lilly and Company analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 6 |
| Buy | 20 |
| Hold | 3 |
| Sell | 1 |
| Strong sell | 1 |
| Consensus | Buy |
31 analysts cover LLY.
Eli Lilly and Company EPS and revenue estimates
The estimate table for the Eli Lilly and Company keeps 2026 EPS $35.22, 2027 EPS $49.71, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $35.22 | $90.79B |
| 2027 | $49.71 | $105.91B |
Is Eli Lilly and Company a buy or sell?
Of the 31 analysts covering Eli Lilly and Company, 26 rate it a buy (6 strong buy and 20 buy), 3 rate it a hold, and 2 rate it a sell (1 sell and 1 strong sell).
The LLY consensus label is Buy, beside 26 buy-side ratings and 2 sell-side ratings.
The average target of $1,442.61 implies +0.3% versus the current price of $1,437.76.
the Eli Lilly and Company closes with 26 buy-side ratings and 2 on the sell side. The headcount is Buy.
Reading the Eli Lilly and Company forecast
Analysts are far apart on LLY. The published low is $940.00, the average is $1,442.61, and the high is $1,650.00.
From today's $1,437.76 print, the LLY average target is +0.3% away.
Most of the LLY coverage agrees: 26 of 31 analysts are on the buy side, 3 are at hold, and 2 are on the sell side, and the published consensus is Buy.
LLY targets have been marked up: $1,514.08 across the last month versus $1,440.10 across the last quarter.
Coverage of LLY is broad at 31 analysts, and the average is a crowd rather than a single desk.
Eli Lilly and Company forecast questions
What is the LLY price target?
The published range for LLY is $940.00 to $1,650.00, with an average of $1,442.61. That average is +0.3% versus the current price of $1,437.76.
Is Eli Lilly and Company a buy or sell?
Of the 31 analysts covering Eli Lilly and Company, 26 rate it a buy, 3 rate it a hold, and 2 rate it a sell. The consensus is Buy, which for LLY is 26 on the buy side, 3 at hold, and 2 on the sell side.
What is the EPS estimate for Eli Lilly and Company?
Analyst EPS estimates for Eli Lilly and Company: 2026 $35.22, 2027 $49.71.
What is the revenue estimate for Eli Lilly and Company?
Analyst revenue estimates for Eli Lilly and Company: 2026 $90.79B, 2027 $105.91B.
How many analysts cover LLY?
31 analysts cover LLY. Their consensus on LLY is Buy, across those 31.